High-Risk Myelodysplastic Syndromes and Hypermethylation of the p15^Ink4B Gene

References

• Bird A. The essentials of DNA methylation. Cell 1992; 70: 5–8
   PubMed Web of Science ®Google Scholar
• Bird A. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209–203
   PubMed Web of Science ®Google Scholar
• Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362–365
   PubMed Web of Science ®Google Scholar
• Pfeifer G. P., Steigerwald S. D., Mueller P. R., Wold B., Riggs A. D. Genomic sequencing and methylation analysis by ligation mediated PCR. Science 1989; 246: 810–813
   PubMed Web of Science ®Google Scholar
• Serrano M., Lee H. W., Chin L., Cordon-Cardo C., Beach D., Depinho R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27–37
   PubMed Web of Science ®Google Scholar
• Counts J. L., Goodman J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 1995; 83: 13–15
   PubMed Web of Science ®Google Scholar
• Jones P. A. DNA methylation errors and cancer. Cancer Res. 1996; 56: 2463–2467
   PubMed Web of Science ®Google Scholar
• Issa J. P. J., Baylin S. B., Herman J. G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia 1997; 11(Supplement 1)S7–S11
   PubMedGoogle Scholar
• Sakai T., Toguchida J., Ohtani N., Yandell D. W., Rapaport J. M., Dryja T. P. Allele-specific hypermethylation of the retinoblastoma, tumor-suppressor gene. Am. J. Hum Genet. 1991; 48: 880–888
   PubMed Web of Science ®Google Scholar
• Herman J. G., Latif R, Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., Linehan W. M., Baylin S. B. Silencing of the VHL, tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 1994; 91: 9700–9704
   PubMed Web of Science ®Google Scholar
• Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C, Baylin S. B., Sidransky D. CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1, in human cancers. Nature Med. 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar
• Herman J. G., Jen J., Merlo A., Baylin S. B. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 1996; 56: 722–727
   PubMed Web of Science ®Google Scholar
• Hannon G. J., Beach D. p15INK4B is a potential effector of TGF-(5-induced cell cycle arrest. Nature 1994; 371: 257–261
   PubMed Web of Science ®Google Scholar
• Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995; 9275: 1149–1163
   Web of Science ®Google Scholar
• Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., III, Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–440
   PubMed Web of Science ®Google Scholar
• Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin-dependent kinases inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756
   PubMed Web of Science ®Google Scholar
• Hirama T., Koeffler H. P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841–854
   PubMed Web of Science ®Google Scholar
• Malumbres M., De Castro I. P., Santos J., Melendez B., Mangues R., Serrano M., Pellicer A., Fernan-Dez-Piqueras J. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo, methylation with independence of p16INK4a alterations in murine T-cell lymphomas. Oncogene 1997; 14: 1361–1370
   PubMed Web of Science ®Google Scholar
• Freiberg A. P., Gehrke C. W., Kuo K. C., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988; 48: 1159–1161
   PubMed Web of Science ®Google Scholar
• Freiberg A. P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89–91
   PubMed Web of Science ®Google Scholar
• Kautianian T. L., Jones P. A. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem. 1986; 261: 1594–1598
   PubMed Web of Science ®Google Scholar
• Laird P. W., Jackson-Grusby L., Fazeli A., Dickinson S. L., Jung W. E., Li E., Weinberg R. A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197–205
   PubMed Web of Science ®Google Scholar
• Issa J. P. J., Vertino P. M., Wu I, Sazawal S., Celano P., Nelkin B. D., Hamliton S. R., Baylin S. B. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer inst 1993; 85: 1235–1240
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., Nikula K. J., Baylin S. B., Issa J. P. J. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA 1996; 93: 4045–4050
   PubMed Web of Science ®Google Scholar
• Wu J., Issa J. P. J., Herman J., Bassett D. E., Jr, Nelkin B. D., Baylin S. B. Expression of exogenous eukaryotic DNA methyltransferase gene induces transformation of N1H 3T3 cells. Proc. Natl. Acad. Sci. USA 1993; 90: 8891–8895
   PubMed Web of Science ®Google Scholar
• Macleod A. R., Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem. 1995; 270: 8037–8043
   PubMed Web of Science ®Google Scholar
• Chuang L. S. H., Ian H. I., Koh T. W., Ng H. H., Xu G., Li B. F. L. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAFI. Science 1997; 277: 1996–2000
   PubMed Web of Science ®Google Scholar
• Kondo M, Matsuoka S., Uchida K., Osada H., Nagatake M, Takagi K., Harper J. W., Takahashi T., Elledge S., Takahashi T. Selective maternal-allele loss in human lung cancers of the maternally expressed p57kip2, gene at 11p15.5. Oncogene 1996; 12: 1365–1368
   PubMed Web of Science ®Google Scholar
• Caron H., Peter M., Van Sluis P., Speleman E, De Kraker J., Laureys G., Miction J., Brugieres L., Voute P. A., Westerveld A. Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum. Mol. Genet. 1995; 4: 535–539
   PubMed Web of Science ®Google Scholar
• Kadhad M., Bonnet H., Yang A., Creancier L., Biscan J. C, Valent A., Minty A., Chalon P., Lelias J. M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809–819
   PubMed Web of Science ®Google Scholar
• Yang A. S., Shen J-C, Zingg J-M., Sha M., Jones P. A. Hhal and Hpall, DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res. 1995; 23: 1380–1387
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler K. W., Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Pwc. Natl. Acad. Sci., USA 1997; 94: 2545–2550
   PubMed Web of Science ®Google Scholar
• Ahuja N., Mohan A. L., Li O., Stolker J. M., Herman J. G., Hamilton S. R., Baylin S. B., Issa J. P. J. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 1997; 57: 3370–3374
   PubMed Web of Science ®Google Scholar
• Denissenko M. E, Chen J. T., Tang M., Pfeifer G. P. Cytosine methylation determines hot spots of DNA damage in the human P53, gene. Proc. Natl. Acad. Sci. USA 1997; 94: 3893–3898
   PubMed Web of Science ®Google Scholar
• Wales M. M., Biel M. A., El Deiry W., Nelkin B. D., Issa J. P. J., Cavenee W. K., Kuerbitz S. J., Baylin S. B. activates expression of HIC-1, a new candidate tumor suppressor gene on 17p1 3.3. Nature Med. 1995; 1: 53, 570–577
   PubMed Web of Science ®Google Scholar
• Herman J. G., Civin C. I, Issa J. P. J., Collector M. I., Sharkis S. J., Baylin S. B. Distinct patterns of inactivation of p15INK4B, and p16INK4A, characterize the major types of hematological malignancies. Cancer Res. 1997; 57: 837–841
   PubMed Web of Science ®Google Scholar
• Batova A., Diccianni M. B., Yu J. C., Nobori T., Link M. P., Pullen J., Yu A. L. Frequent and selective methylation of p/5and deletion of both p15, and p16, in T-cell acute lymphoblastic leukemia. Cancer Res. 1997; 57: 832–836
   PubMed Web of Science ®Google Scholar
• Ng M. H. L., Chung Y E, Lo K. W., Wickham N. W. R., Lee J. C. K., Huang D. P. Frequent hypermethylation of p16INK4A and p15INK4B, genes in multiple myeloma. Blood 1997; 89: 2500–2506
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Fearon E. R., Vogelstein B, De Bustros A., Sharkis S. J., Burke P. J., Staal S. P., Nelkin B. D. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood 1987; 70: 412–417
   PubMed Web of Science ®Google Scholar
• Issa J. P. J., Kopecky K. J., Applebaum E, Willman C., Baylin S. B. Estrogen receptor methylation is a favorable prognostic factor in AML. Proc. Am. Sot: Clin. Oncol. 1996; 15: 357
   Google Scholar
• Issa J. P. J., Zehnbauer B. A., Kaufmann S. H., Biel M. A., Baylin S. B. HICl, hypermethylation is a late event in hematopoietic neoplasms. Cancer Res. 1997; 57: 1678–1681
   PubMed Web of Science ®Google Scholar
• Nelkin B. D., Przepiorka D., Burke P. J., Thomas E. D., Baylin S. B. Abnormal methylation of the carcilonin, gene marks progression of chronic myelogenous leukemia. Blood 1991; 77: 2431–2434
   PubMed Web of Science ®Google Scholar
• Issa J. P. J., Zehnbauer B. A., Civin C. I., Collector M. I., Sharkis S. J., Davidson N. E., Kaufmann S. H., Baylin S. B. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res. 1996; 56: 973–977
   PubMed Web of Science ®Google Scholar
• Zion M., Ben-Yehuda D., Avraham A., Cohen O., Wetzler M., Melloul D., Ben-Neriah Y. Progressive de novo, DNA methylation at the bcr-abl, locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1994; 91: 10722–10726
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. The French-American-British (FAB) cooperative group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Greenberg P., Cox C, Lebeau M., Fenaux P., Morel P., Sanz G., Sanz M., Vallepsi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C, Multi G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088
   PubMed Web of Science ®Google Scholar
• Uchida T, Kinoshita T., Nagai H., Nakahara Y, Saito H., Hotta T., Murate T. Hypermethylation of the p15INK4B, gene in myelodysplastic syndromes. Blood 1997; 90: 1403–1409
   PubMed Web of Science ®Google Scholar
• Nakamaki T., Kawamata N., Schwaller J., Tobler A., Fey M., Pakkala S., Lee Y. Y, Kim B. K., Fukuchi K., Tsu-Ruoka N., Kahan J., Miller C. W., Koeffler H. P. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16, p18, in myeloid leukaemias. Br. J. Haematol. 1995; 91: 139–149
   PubMed Web of Science ®Google Scholar
• Nakamaki T., Bartram C, Seriu T., Kahan J., Fukuchi K., Tsuruoka N., Janssen J. W. G., Miller C. W., Koeffler H. P. Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18, and p 19, in the myelodysplastic syndromes. Leukemia Res. 1997; 21: 235–240
   PubMed Web of Science ®Google Scholar
• Issa J. P. J., Ottaviano Y L., Celano P., Hamilton S. R., Davidson N. E., Baylin S. B. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat. Genet. 1994; 7: 536–540
   PubMed Web of Science ®Google Scholar
• Singer-Sam J., Grant M., Lebon J. M., Okuyama K., Chapman V., Monk M., Riggs A. D. Use of a Hpall-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol. Cell Biol. 1990; 10: 4987–4989
   PubMed Web of Science ®Google Scholar
• Asano H., Ohashi H., Ichikawa M., Kinoshita T., Murate T., Kobayashi M., Saito H., Hotta T. Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 1994; 84: 588–594
   PubMed Web of Science ®Google Scholar
• Ito T, Ohashi H., Kagami Y., Ichikawa A., Saito H., Hotta T. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia 1994; 8: 839–843
   PubMed Web of Science ®Google Scholar
• Delforge M., Demuynck H., Vandenberghe P., Verhoef G., ZachÉE P., Duppen V. V., Marijnen P., Berghe H. V., Boogaerts M. A. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood 1995; 86: 3660–3667
   PubMed Web of Science ®Google Scholar
• Herman J. G., Graff J. R., Myöhänsen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996; 93: 9821–9826
   PubMed Web of Science ®Google Scholar
• Gonzalgo M. L., Jones P. A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extention (Ms-SNuPE). Nucleic Acids Res. 1997; 25: 2529–2531
   PubMed Web of Science ®Google Scholar
• Xiong Z., Laird P. W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997; 25: 2532–2534
   PubMed Web of Science ®Google Scholar
• Wijermans P. W., Krulder J. W. M, Huijgens P. C., Neve P. Continuous infusion of low-dose 5-aza-2′-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia 1997; 11: S19–S23, Supplement 1
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M, O'Brien S. M., Estey E., Giralt S., Beran M., Rios M. B., Keating M., De Vos D., Talpaz M. Decitabine studies in chronic and acute myelogenous leukemia. Leukemia 1997; 11: S35–S36, Supplement 1
   PubMed Web of Science ®Google Scholar
• Giralt S., Davis M., O'Brien S., Van Besien K., Champlin R., De Vos D., Kantarjian H. M. Studies of decitabine with allogeneic progenitor cell transplantation. Leukemia 1997; 11: S32–S34, Supplement 1
   PubMed Web of Science ®Google Scholar
• Tsubari M., Tiihonen E., Laiho M. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor. Cancer Res. 1997; 57: 2966–2973
   PubMed Web of Science ®Google Scholar
• Quelle D. E., Zindy R, Ashmun R. A., Sherr C. J. Alternative reading frames of the lNK4a, tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993–1000
   PubMed Web of Science ®Google Scholar
• Rideout W. M., III, Eversole-Cure P., Spruck C. H., III, Hustad C. M., Coetzee G. A., Gonzales F., Jones P. A. Progressive increases in the methylation status and heterochromatinization of the MyoD, CpG island during oncogenic transformation. Mol. Cell Biol 1994; 14: 6143–6152
   PubMed Web of Science ®Google Scholar
• Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugiura T., Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 1995; 92: 7416–7419
   PubMed Web of Science ®Google Scholar